US Stock MarketDetailed Quotes

KZIA Kazia Therapeutics

Watchlist
  • 3.020
  • -0.010-0.33%
Close Dec 20 16:00 ET
  • 3.020
  • 0.0000.00%
Post 20:01 ET
13.15MMarket Cap-0.48P/E (TTM)

About Kazia Therapeutics Company

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Company Profile

SymbolKZIA
Company NameKazia Therapeutics
Listing DateJan 7, 1999
Founded1994
CEODr. John E. Friend, II,M.D.
MarketNASDAQ
Employees7
Securities TypeDR
ADS Ratio1.0 : 100.0
Fiscal Year Ends06-30
AddressThree International Towers,300 Barangaroo Avenue,Level 24
CitySydney
ProvinceNew South Wales (NSW)
CountryAustralia
Zip Code2000
Phone61-2-9472-4101

Company Executives

  • Name
  • Position
  • Salary
  • Dr. John E. Friend, II,M.D.
  • Director, Managing Director and Chief Executive Officer
  • 1.28M
  • Jeffrey Bonacorda
  • Vice President, Finance and Controller
  • --
  • Bryce D. Carmine
  • Non-Executive Chairman of the Board
  • 95.42K
  • Robert F. Apple
  • Director
  • 39.30K
  • Steven Coffey
  • Independent Director
  • 94.35K
  • Ebru Davidson
  • Independent Director
  • 94.35K
  • Elissa Hansen
  • Company Secretary
  • 2.27K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.